This is a federal contract award issued by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada. The contract, valued at $349,110.00, is for the delivery of pyridostigmine bromide, which is used as a nerve agent treatment. The contract is a firm fixed-price delivery order with an ultimate completion date of May 31, 2017. CCC, which serves as a prime contractor for U.S. federal agencies, has been awarded numerous contracts by various agencies, including the Naval Air Warfare Center, the U.S. Army Contracting Command, and the DLA Aviation, for the supply of a wide range of products and services, such as aircraft components, ammunition, and specialized equipment. This contract does not have a set-aside designation.